Estimation of effective intake of whey protein hydrolysate for stimulating muscle protein synthesis by using blood components as markers
Not Applicable
- Conditions
- Healthy person
- Registration Number
- JPRN-UMIN000021108
- Lead Sponsor
- Meiji Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1) Seriously or progressive ill patients 2) Patients with liver or kidney dysfunction 3) Patients with food allergies 4) Patients with congenital aminoacidopathy 5) HBsAg or HCVAb positive patients 6) Persons who donated blood within 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma leucine concentration 0-120 min after ingestion of whey protein hydrolysate or essential amino acids
- Secondary Outcome Measures
Name Time Method 1)Plasma concentration of the following items 0-120 min after ingestion of whey protein hydrolysate or essential amino acids; essential amino acids, insulin, IGF-1 and 3-methyl-histidine 2)Blood glucose level 0-120 min after ingestion of whey protein hydrolysate or essential amino acids